Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, septembre 18
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
BrightSpring Health Services Inc
BTSG
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$56.78
0.18
0.32%
À la clôture: Sep 18, 5:00 PM EST
$56.78
-0.0025
0%
Après les heures: 4:28 PM EST
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
BrightSpring Health Financials
BrightSpring Health (BTSG) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate
BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.40 by 12.5 percent. This is a 104.55 percent increase over earnings of $0.22 per share
Benzinga Newsdesk
PRO
BrightSpring Health Raises FY2026 Sales Guidance from $14.725B-$15.225B to $15.100B-$15.425B vs $15.064B Est
BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $14.725 billion-$15.225 billion to $15.100 billion-$15.425 billion vs $15.064 billion estimate.
Benzinga Newsdesk
BrightSpring Health Analysts Increase Their Forecasts Following Q1 Results
BrightSpring Health Services (BTSG) reported strong Q1 results with increased full-year guidance. Analysts have raised price targets for stock.
Avi Kapoor
BrightSpring Extends Rally With Solid Q1, Upgraded Fiscal 2026 Forecast
BrightSpring shares rise after Q1 earnings beat, revenue growth and raised FY26 guidance; analysts cite momentum but note valuation premium.
Vandana Singh
Earnings Scheduled For May 1, 2026
Benzinga Insights
PRO
BrightSpring Health Raises FY2026 Sales Guidance from $14.450B-$15.000B to $14.725B-$15.225B vs $14.847B Est
Full Year 2026 Financial GuidanceFor the full year 2026, BrightSpring is increasing Revenue and Adjusted EBITDA guidance, which excludes the Community Living business and the effects of any future closed acquisitions.
Benzinga Newsdesk
Privacy Manager